We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
AUM
$300M
AUM Growth
-$5.12M
Cap. Flow
+$2.3M
Cap. Flow %
0.77%
Top 10 Hldgs %
11.57%
Holding
270
New
33
Increased
92
Reduced
83
Closed
33

Sector Composition

Rank Sector Weight
1 Financials 23.93%
2 Industrials 17.69%
3 Consumer Discretionary 11.11%
4 Technology 9.66%
5 Real Estate 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNCR icon
226
Xencor
XNCR
$1.55B
$252K 0.08%
8,420
-1,320
-14% -$34.5K
IPGP icon
227
IPG Photonics
IPGP
$3.84B
$250K 0.08%
1,070
KYNB
228
Kyntra Bio
KYNB
$29.4M
$231K 0.08%
200
-34
-15% -$44.8K
PAHC icon
229
Phibro Animal Health
PAHC
$1.39B
$223K 0.07%
+5,610
New +$208K
VNDA icon
230
Vanda Pharmaceuticals
VNDA
$302M
$215K 0.07%
12,730
-2,020
-14% -$33.8K
HALO icon
231
Halozyme
HALO
$12.2B
$206K 0.07%
+10,500
New +$203K
AMPH icon
232
Amphastar Pharmaceuticals
AMPH
$916M
$204K 0.07%
10,870
-1,860
-15% -$35K
CNSL
233
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$183K 0.06%
16,741
-2,709
-14% -$32.5K
TTSH
234
DELISTED
Tile Shop Holdings
TTSH
$138K 0.05%
23,050
-2,930
-11% -$22.7K
INO icon
235
Inovio Pharmaceuticals
INO
$69M
$127K 0.04%
2,253
-441
-16% -$23.9K
CYTK icon
236
Cytokinetics
CYTK
$10.4B
$119K 0.04%
16,530
-2,600
-14% -$22.3K
AKBA icon
237
Akebia Therapeutics
AKBA
$252M
$103K 0.03%
10,830
-1,670
-13% -$23.4K
BDC icon
238
Belden
BDC
$5.19B
-11,074
Closed -$855K
CIM
239
Chimera Investment
CIM
$1B
-39,351
Closed -$2.18M
CRAI icon
240
CRA International
CRAI
$1.06B
-41,073
Closed -$1.85M
EEFT icon
241
Euronet Worldwide
EEFT
$2.7B
-5,970
Closed -$503K
EFSC icon
242
Enterprise Financial Services Corp
EFSC
$2.39B
-48,553
Closed -$2.19M
DMC
243
Del Monte Corp
DMC
$1.45B
-8,250
Closed -$393K
FLR icon
244
Fluor
FLR
$7.96B
-4,850
Closed -$251K
GOOD
245
Gladstone Commercial Corp
GOOD
$627M
-101,740
Closed -$2.14M
LPLA icon
246
LPL Financial
LPLA
$28.6B
-53,800
Closed -$3.07M
LZB icon
247
La-Z-Boy
LZB
$1.69B
-42,700
Closed -$1.33M
MASI
248
DELISTED
Masimo
MASI
-7,220
Closed -$612K
MSA icon
249
Mine Safety
MSA
$7.49B
-5,940
Closed -$460K
MUSA icon
250
Murphy USA
MUSA
$9.61B
-26,370
Closed -$2.12M

Similar funds

Piermont Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Piermont Capital Management held 270 positions worth $300M, down 1.7% from $305M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Piermont Capital Management's Q1 2018 filing shows 33 new, 92 increased, 83 reduced and 33 closed positions. Its largest new stake was Electro Scientific Industries: 136,150 shares worth $2.63M. The largest sale was Sucampo Pharmaceuticals, Inc., an estimated $3.1M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Piermont Capital Management's largest Q1 2018 buy was Electro Scientific Industries: 136,150 shares worth $2.63M.
  • Piermont Capital Management added most to Meridian Bancorp, Inc. in Q1 2018, an estimated $1.67M increase.
  • Piermont Capital Management's biggest Q1 2018 reduction was Spire, cutting an estimated $2.64M.
  • Piermont Capital Management fully exited Sucampo Pharmaceuticals, Inc. in Q1 2018, selling an estimated $3.1M.
  • Piermont Capital Management's ten largest holdings make up 12% of its $300M portfolio in Q1 2018.
  • Piermont Capital Management opened 33 new positions and closed 33 in Q1 2018.
  • Piermont Capital Management's portfolio value fell 1.7% quarter-over-quarter to $300M.

Based on Piermont Capital Management's 13F filing for Q1 2018, filed 9 May 2018.